Breakdown | |||||
TTM | Sep 2024 | Sep 2023 | Sep 2022 | Sep 2021 | Sep 2020 |
---|---|---|---|---|---|
Income Statement | Total Revenue | ||||
5.13B | 19.48M | 24.16M | 35.40M | 44.48M | 41.88M |
Gross Profit | |||||
3.41B | 12.00M | 14.98M | 22.34M | 29.99M | 26.37M |
EBIT | |||||
-88.52M | -3.32M | -9.27M | 35.81M | -19.62M | -17.58M |
EBITDA | |||||
-87.13M | -1.49M | -7.47M | -15.48M | -22.01M | -16.86M |
Net Income Common Stockholders | |||||
-3.69M | -3.70M | -22.94M | -74.09M | -23.39M | 12.60M |
Balance Sheet | Cash, Cash Equivalents and Short-Term Investments | ||||
1.97M | 2.45M | 1.80M | 7.72M | 27.44M | 15.10M |
Total Assets | |||||
11.54M | 10.58M | 16.20M | 40.79M | 124.88M | 110.84M |
Total Debt | |||||
1.63M | 1.27M | 3.68M | 4.87M | 6.07M | 8.68M |
Net Debt | |||||
-344.85K | -1.18M | 1.89M | -1.85M | -20.34M | -6.14M |
Total Liabilities | |||||
9.76M | 8.62M | 7.16M | 9.37M | 21.74M | 31.66M |
Stockholders Equity | |||||
1.78M | 1.96M | 9.03M | 31.42M | 103.14M | 79.18M |
Cash Flow | Free Cash Flow | ||||
-834.63K | -642.81K | -4.60M | -15.66M | -16.44M | -11.98M |
Operating Cash Flow | |||||
-564.86K | -352.79K | -4.30M | -14.97M | -14.09M | -10.66M |
Investing Cash Flow | |||||
-164.49M | -290.01K | 702.45K | -688.68K | -2.55M | -1.57M |
Financing Cash Flow | |||||
1.30M | 1.30M | -1.32M | -4.04M | 28.23M | 22.37M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
68 Neutral | C$979.28M | 17.25 | 3.80% | ― | 35.87% | ― | |
49 Neutral | $6.85B | 0.81 | -52.91% | 2.50% | 17.48% | 1.17% | |
48 Neutral | $1.50M | ― | -60.98% | ― | -18.02% | 78.28% | |
47 Neutral | $347.96M | 27.27 | 4.78% | ― | 16.39% | -98.10% | |
39 Underperform | $1.71M | ― | -6.52% | ― | -18.87% | 20.00% | |
37 Underperform | $3.47M | ― | 230.64% | ― | ― | ― |
cbdMD, Inc. announced the appointment of T. Ronan Kennedy, its current CEO and CFO, to the Board of Directors, expanding it to five members. Under Kennedy’s leadership, the company has stabilized, optimized its cost structure, and improved operational fundamentals, positioning itself for long-term success. His appointment is expected to enhance the company’s strategic capabilities and shareholder value.